Cargando…

Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies

BACKGROUND: Drug-coated balloons (DCBs) are a predominant revascularization therapy for symptomatic femoropopliteal artery disease. Because of the differences in excipients, paclitaxel dose, and coating morphologies, varying clinical outcomes have been observed with different DCBs. We report the res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krishnan, Prakash, Faries, Peter, Niazi, Khusrow, Jain, Ash, Sachar, Ravish, Bachinsky, William B., Cardenas, Joseph, Werner, Martin, Brodmann, Marianne, Mustapha, J. A., Mena-Hurtado, Carlos, Jaff, Michael R., Holden, Andrew H., Lyden, Sean P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598919/ https://www.ncbi.nlm.nih.gov/pubmed/28729250 http://dx.doi.org/10.1161/CIRCULATIONAHA.117.028893

Ejemplares similares

Stellarex drug‐coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12‐Month results from a prospective, multicenter, single‐arm study
por: Schroë, Herman, et al.
Publicado: (2017)

Mortality Assessment of Paclitaxel-Coated Balloons: Patient-Level Meta-Analysis of the ILLUMENATE Clinical Program at 3 Years
por: Gray, William A., et al.
Publicado: (2019)

Low-Dose Paclitaxel–Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon)
por: Schroeder, Henrik, et al.
Publicado: (2017)

Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial
por: Schneider, Peter A., et al.
Publicado: (2018)

Two‐year results of a low‐dose drug‐coated balloon for revascularization of the femoropopliteal artery: Outcomes from the ILLUMENATE first‐in‐human study
por: Schroeder, Henrik, et al.
Publicado: (2015)

Effective Endovascular Treatment of Calcified Femoropopliteal Disease With Directional Atherectomy and Distal Embolic Protection: Final Results of the DEFINITIVE Ca(++) Trial
por: Roberts, David, et al.
Publicado: (2014)

Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort
por: Torsello, Giovanni, et al.
Publicado: (2020)

Drug-Coated Balloon Treatment of Femoropopliteal Lesions Typically Excluded From Clinical Trials: 12-Month Findings From the IN.PACT Global Study
por: Ansel, Gary M., et al.
Publicado: (2018)

Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease
por: Müller-Hülsbeck, Stefan, et al.
Publicado: (2016)

The RANGER II superficial femoral artery trial: 1-year results of the long lesion cohort
por: Schroë, Herman, et al.
Publicado: (2022)

Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions: Five-Year Outcomes From the IN.PACT SFA Randomized Trial
por: Laird, John A., et al.
Publicado: (2019)

Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease
por: Hanna, Jonathan, et al.
Publicado: (2023)

Twelve-Month Results From the First-in-China Prospective, Multi-Center, Randomized, Controlled Study of the FREEWAY Paclitaxel-Coated Balloon for Femoropopliteal Treatment
por: Zhang, Bihui, et al.
Publicado: (2021)

Critical Review of the Ankle Brachial Index
por: Khan, Tahir H, et al.
Publicado: (2008)

Use of the Stingray Re-Entry System in Two Complex Cases of Occluded Superficial Femoral Arteries
por: Galbraith, Erin M., et al.
Publicado: (2011)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Algorithm of Femoropopliteal Endovascular Treatment
por: Dubosq, Maxime, et al.
Publicado: (2022)

The Effect of Severe Femoropopliteal Arterial Calcification on the Treatment Outcome of Femoropopliteal Intervention in Patients with Ischemic Tissue Loss
por: Lee, Hyun Yong, et al.
Publicado: (2020)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial
por: Dake, Michael D., et al.
Publicado: (2016)

Safety and effectiveness of the Phoenix Atherectomy System in lower extremity arteries: Early and midterm outcomes from the prospective multicenter EASE study
por: Davis, Thomas, et al.
Publicado: (2017)

Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries
por: Pastromas, Georgios, et al.
Publicado: (2014)

Femoropopliteal Bypasses with Varicose Great Saphenous Vein
por: Kuma, Sosei, et al.
Publicado: (2022)

Endovascular Sharp Recanalization for Calcified Femoropopliteal Artery Occlusion
por: Huang, Hsuan-Li, et al.
Publicado: (2012)

Factors Affecting Recanalization in Femoropopliteal Deep Vein Thrombosis
por: Erol, Mehmet Emir, et al.
Publicado: (2023)

Bilateral giant femoropopliteal artery aneurysms: a case report
por: Perdikides, Theodossios P, et al.
Publicado: (2008)

Percutaneous mechanical thrombectomy for treatment of acute femoropopliteal bypass occlusion
por: Lichtenberg, Michael, et al.
Publicado: (2012)

Combination of Rotational Atherothrombectomy and Paclitaxel-Coated Angioplasty for Femoropopliteal Occlusion
por: Scheer, F, et al.
Publicado: (2015)

Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive
por: Takahara, Mitsuyoshi, et al.
Publicado: (2019)

Relationship Between Lipoprotein(a) and Angiographic Severity of Femoropopliteal Lesions
por: Yanaka, Koji, et al.
Publicado: (2021)

State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?
por: Mosarla, Ramya C., et al.
Publicado: (2022)

Popliteal access for endovascular procedures in femoropopliteal artery occlusive disease
por: Yilmaz, Seyhan, et al.
Publicado: (2023)

Technique and early results of percutaneous femoropopliteal bypass with stent graft
por: Sarradon, Pierre, et al.
Publicado: (2023)

Prognostic factors for femoropopliteal vascular injuries: surgical decisions matter
por: Góes, Adenauer Marinho de Oliveira, et al.
Publicado: (2023)

Five-Year Outcomes after Paclitaxel Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Diabetic and Chronic Limb-Threatening Ischemia Cohorts: IN.PACT Global Study Post Hoc Analysis
por: Reijnen, Michel M. P. J., et al.
Publicado: (2023)

The first of twelve
Publicado: (1969)

Twelve moons
Publicado: (1993)

Volume Twelve
Publicado: (1895)

Volume Twelve
Publicado: (1872)

When Are Endovascular and Open Bypass Treatments Preferred for Femoropopliteal Occlusive Disease?
por: AbuRahma, Ali F.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e6jon0rtmidp05m1n1k0bplc3a